Comment on BMJ: https://www.bmj.com/content/376/bmj.o618.full?ijkey=LZFTb5pdZ4hAr9H&keytype=ref So we are back to the tiering argument when NHS tiering is common: waiting lists, regional variations, etc. But the tiering in provision is exacerbated by the failure to use purchasing that is agnostic to ownership.… Read More »The continuing fear of two-tier healthcare
The Covid pandemic has entailed a range of restrictions on our freedoms. It has led lawmakers to act in ill-liberal ways that go beyond what is actually necessary. There are two areas of concern in this post: The first is how… Read More »Quarantines and ageism
NI is a type of ‘insurance’ that morphed into a tax which in reality is a just another type of tax on income. It is used to pay for things like the NHS and other public benefits. BUT, is it… Read More »National Insurance [NI] is a tax that should be repurposed
Comment on: Revisiting academic health sciences systems a decade later: discovery to health to population to society https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01752-9/fulltext Timely update in Lancet on academic health science systems. These organisations have the missions of research, teaching and clinical services plus this… Read More »Academic Health Science Centres, revisited
Market access is wrapped in the politics of health The attention politicians and stakeholders pay to healthcare and its challenges is a keen driver of the ease or difficulty companies experience with drug regulation and market access and has implications… Read More »The politics of market access
We are in a new world when it comes to access to and the use of data and evidence. Real world data and evidence takes us from structured studies to the routine delivery of healthcare, actual use of a medicine,… Read More »Real world data and evidence in healthcare: The market access challenge
To some extent Academic Health Science Centres [AHSCs] are caught between the research push and market pull. If they prioritise technology transfer, they opt for a research push approach that emphasises the availability of technologies or innovations for market-based actors… Read More »Innovation and Academic Health Science Centres
It is not unreasonable to have concerns about the cost of medicines. Drug costs are usually influenced by government policies on pricing and reimbursement of medicines themselves. These range from simple discount seeking to more complex approaches such as conditional… Read More »Managerial control of medicines cost drivers
Healthcare systems have been slowly evolving toward a model of care delivery that seeks to leave behind the traditional medical model, based on fighting diseases – sometimes called the lesion-theory of medicine – and which has driven health care thinking… Read More »Healthcare Cognology: autonomous agency for patient empowerment and system reform
Discussions on health literacy are increasing as healthcare providers, clinicians, payers and patients consider what this means for healthcare. Having been involved in launching the world’s first digital interactive health channel in the UK in 2000, one thing I learned… Read More »9 Tribes of the Internet and their health interests